Mehta, Rohtesh S <br/><br/>
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.  [electronic resource] 

 -  Blood advances  05 2019 
 - 1441-1449 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2018030171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Alemtuzumab--therapeutic use<br/>Bone Marrow Cells--cytology<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Fetal Blood--cytology<br/>Graft vs Host Disease--etiology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Leukemia, Myeloid, Acute--mortality<br/>Male<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--mortality<br/>Proportional Hazards Models<br/>Recurrence<br/>Survival Rate<br/>Thyroglobulin--therapeutic use<br/>Transplantation Conditioning<br/>Whole-Body Irradiation